<DOC>
	<DOCNO>NCT02371122</DOCNO>
	<brief_summary>The purpose study evaluate effect different spinal cord stimulation setting treatment leg pain . Subjects receive randomize order four different program stimulation setting 3 week follow fifth final setting .</brief_summary>
	<brief_title>Spinal Cord Stimulation ( SCS ) Therapy Study</brief_title>
	<detailed_description />
	<mesh_term>Radiculopathy</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<mesh_term>Failed Back Surgery Syndrome</mesh_term>
	<mesh_term>Arachnoiditis</mesh_term>
	<criteria>At least 22 year age old time inform consent Implanted Medtronic RestoreSensor RestoreUltra SCS system onlabel indication least 6 month treatment chronic leg pain , without back pain Implanted one Medtronic lead locate epidural space within thoracic area Receiving level pain relief current SCS therapy On stable dose ( new , discontinue change ) prescription pain medication willing maintain decrease dose prescribe pain medication Read understand English without assistance Willing able comply study procedure , study visit , available duration study Diagnosed complex regional pain syndrome ( CRPS ) , peripheral causalgia , reflex sympathetic dystrophy ( RSD ) , causalgia Has leg , knee , foot pain unrelated onlabel indication SCS therapy ( eg , arthritis , knee surgery , etc . ) Implanted surgical percutaneous lead Implanted peripheral lead subcutaneous peripheral nerve stimulation Has following procedure : Neuroablative procedure within six month Neurolytic block within two month Injection therapy pain within four week Sympathetic block within two week Has active implant device ( besides RestoreUltra RestoreSensor neurostimulator ) , whether turn ON OFF Pregnant lactating , inadequate birth control , risk pregnancy study Has untreated psychiatric comorbidity Has serious drugrelated behavioral issue Has active malignancy diagnose cancer remission least one year Has secondary gain , opinion investigator , likely interfere study Participating plan participate another clinical trial enrol study</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>